EML4-ALK V3 drives cell migration through NEK9 and NEK7 kinases in non-small-cell lung cancer
Authors:
- Laura O’reganLOLaura O’regan
- Giancarlo BaroneGBGiancarlo Barone
- Rozita AdibRARozita Adib
- Chang Gok WooCWChang Gok Woo
- Hui Jeong JeongHJHui Jeong Jeong
- Emily L. RichardsonEREmily L. Richardson
- Mark W. RichardsMRMark W. Richards
- Patricia A.J. MullerPatricia A.J. Muller
- Spencer J. CollisSpencer J. Collis
- Dean A. FennellDFDean A. Fennell
- Jene ChoiJCJene Choi
Preprint
Abstract
EML4-ALK is an oncogenic fusion present in ∼5% lung adenocarcinomas. However, distinct EML4-ALK variants differ in the length of the EML4 microtubule-associated protein encoded within the fusion and are associated with a poorly understood variability in disease progression and therapeutic response. Here, we show that EML4-ALK variant 3, which is linked to accelerated metastatic spread and worse patient outcome, causes microtubule stabilization, formation of extended cytoplasmic protrusions, loss of cell polarity and increased cell migration. Strikingly, this is dependent upon the NEK9 kinase that interacts with the N-terminal region of EML4. Overexpression of wild-type EML4, as well as constitutive activation of NEK9, also perturbs cell morphology and accelerates cell migration in a manner that requires the downstream kinase NEK7 but not ALK activity. Moreover, elevated NEK9 is associated in patients with EML4-ALK V3 expression, as well as reduced progression-free and overall survival. Hence, we propose that EML4-ALK V3 promotes microtubule stabilization through recruitment of NEK9 and NEK7 to increase cell migration and that this represents a novel actionable pathway that drives disease progression in lung cancer.Keywords
This publication has 53 references indexed in Scilit:
- Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung CancerNew England Journal of Medicine, 2013
- Nek family of kinases in cell cycle, checkpoint control and cancerCell Division, 2011
- DYNLL/LC8 Protein Controls Signal Transduction through the Nek9/Nek6 Signaling Module by Regulating Nek6 Binding to Nek9Journal of Biological Chemistry, 2011
- Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion OncogeneCancer Research, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- The biology and treatment of EML4-ALK non-small cell lung cancerEuropean Journal of Cancer, 2010
- An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9Molecular Cell, 2009
- The Nek6 and Nek7 Protein Kinases Are Required for Robust Mitotic Spindle Formation and CytokinesisMolecular and Cellular Biology, 2009
- NEK7 is a centrosomal kinase critical for microtubule nucleationBiochemical and Biophysical Research Communications, 2007
- Large‐scale mapping of human protein–protein interactions by mass spectrometryMolecular Systems Biology, 2007